SG46389G - Improvements in and relating to pyrimido(4,5-g)quinolines and intermediates - Google Patents

Improvements in and relating to pyrimido(4,5-g)quinolines and intermediates

Info

Publication number
SG46389G
SG46389G SG46389A SG46389A SG46389G SG 46389 G SG46389 G SG 46389G SG 46389 A SG46389 A SG 46389A SG 46389 A SG46389 A SG 46389A SG 46389 G SG46389 G SG 46389G
Authority
SG
Singapore
Prior art keywords
pyrimido
quinolines
intermediates
relating
Prior art date
Application number
SG46389A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/535,474 external-priority patent/US4521421A/en
Priority claimed from US06/535,503 external-priority patent/US4501890A/en
Priority claimed from US06/575,126 external-priority patent/US4528290A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SG46389G publication Critical patent/SG46389G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG46389A 1983-09-26 1989-07-28 Improvements in and relating to pyrimido(4,5-g)quinolines and intermediates SG46389G (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US53551983A 1983-09-26 1983-09-26
US06/535,474 US4521421A (en) 1983-09-26 1983-09-26 Treatment of sexual dysfunction
US06/535,503 US4501890A (en) 1983-09-26 1983-09-26 Trans-(±)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyrimido[4,5-g]quinolines
US06/575,126 US4528290A (en) 1984-01-30 1984-01-30 Stimulating dopamine D-1 receptors
US60609184A 1984-05-02 1984-05-02

Publications (1)

Publication Number Publication Date
SG46389G true SG46389G (en) 1989-12-22

Family

ID=27541855

Family Applications (1)

Application Number Title Priority Date Filing Date
SG46389A SG46389G (en) 1983-09-26 1989-07-28 Improvements in and relating to pyrimido(4,5-g)quinolines and intermediates

Country Status (16)

Country Link
EP (1) EP0139393B1 (el)
JP (1) JPH01151581A (el)
AU (2) AU569539B2 (el)
CY (1) CY1495A (el)
DE (1) DE3484583D1 (el)
DK (4) DK164867C (el)
FI (1) FI78091C (el)
GB (1) GB2146985B (el)
GR (1) GR80201B (el)
HK (1) HK98789A (el)
IE (1) IE57848B1 (el)
IL (1) IL72730A (el)
NZ (1) NZ209295A (el)
PT (1) PT79112B (el)
RO (1) RO89126A (el)
SG (1) SG46389G (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ212947A (en) * 1984-08-03 1988-07-28 Lilly Co Eli Preparation of tricyclic quinoline derivatives
US4764609A (en) * 1986-03-31 1988-08-16 Eli Lilly And Company Synthesis of 2-aminopyrimido[4,5-g]quinolines
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
JPS59202892A (ja) * 1983-05-04 1984-11-16 Ricoh Co Ltd 光学的情報記録媒体
US4507478A (en) * 1983-09-26 1985-03-26 Eli Lilly And Company 2-Mercaptopyrimidohexahydroquinolines and related compounds
NZ212947A (en) * 1984-08-03 1988-07-28 Lilly Co Eli Preparation of tricyclic quinoline derivatives

Also Published As

Publication number Publication date
NZ209295A (en) 1987-05-29
AU569539B2 (en) 1988-02-04
AU8216887A (en) 1988-03-31
EP0139393A2 (en) 1985-05-02
DK164867C (da) 1993-11-08
IE57848B1 (en) 1993-04-21
FI843282A (fi) 1985-03-27
DE3484583D1 (de) 1991-06-20
GB2146985A (en) 1985-05-01
GB8421160D0 (en) 1984-09-26
RO89126A (ro) 1986-04-30
DK400984D0 (da) 1984-08-22
JPH0529398B2 (el) 1993-04-30
DK296190A (da) 1990-12-13
DK296290A (da) 1990-12-13
DK400984A (da) 1985-03-27
IE842154L (en) 1985-03-26
AU585473B2 (en) 1989-06-15
AU3228084A (en) 1985-04-04
PT79112B (en) 1986-11-14
DK169622B1 (da) 1994-12-27
DK169970B1 (da) 1995-04-18
DK164867B (da) 1992-08-31
DK296390A (da) 1990-12-13
FI843282A0 (fi) 1984-08-20
PT79112A (en) 1984-09-01
JPH01151581A (ja) 1989-06-14
HK98789A (en) 1989-12-22
GB2146985B (en) 1987-05-28
DK169948B1 (da) 1995-04-10
DK296190D0 (da) 1990-12-13
DK296390D0 (da) 1990-12-13
IL72730A (en) 1987-10-30
FI78091C (fi) 1989-06-12
IL72730A0 (en) 1984-11-30
CY1495A (en) 1990-02-16
EP0139393B1 (en) 1991-05-15
GR80201B (en) 1985-01-02
DK296290D0 (da) 1990-12-13
FI78091B (fi) 1989-02-28
EP0139393A3 (en) 1988-01-13

Similar Documents

Publication Publication Date Title
GB2197219A (en) Improvements in filters
ZA846467B (en) Pyrimido(4,5-q)quinolines and intermediants
GB8531488D0 (en) Producing duplicates in colour
PH24451A (en) New pteridines and their use as pharmaceuticla agents
GB2153883B (en) Improvements in cutter-bit assemblies
GB2168578B (en) Improvements in or relating to equalizers
GB2146984B (en) Improvements in and relating to pyrazoloquinolines and intermediates
EP0170247A3 (en) Hemoglobin-containing liposomes and process for preparing the same
DE3563968D1 (en) Phospholipids, their production and use
GB2144945B (en) Improvements in or relating to telephone sets
GB2184531B (en) Improvements in or relating to rec
CY1495A (en) Improvements in and relating to pyrimido(4,5-g)quinolines and intermediates
GB2145899B (en) Improvements in or relating to telecines
GB8527466D0 (en) Lymphokine
GB2149305B (en) Improvements in or relating to ear piercing
EG16678A (en) Improvements in and relating to pyrimido(4,5-g)quinolines and intermediates
GB2161342B (en) Improvements in or relating to communication apparatus
GB8518052D0 (en) Carrying out functions in aircraft
AR242033A1 (es) Un procedimiento para la preparacion de un derivado de 2-amino-pirimido(4,5-g)-quinolina y lactamas de aplicacion exclusiva en dicho procedimiento.
GB2169477B (en) Improvements in or relating to communication receivers
IL73884A (en) Aspidosperimidine-3-carboxylic acid derivatives and their use in preparing vincristine
GB2181681B (en) Improvements in rolling universal flats
PH21499A (en) Improvements in or relating to tricyclic quinoline derivatives
IE831774L (en) PYRAZOLO (3,4-g) QUINOLINE
GB8316972D0 (en) Multi-purpose electrode